Trials / Completed
CompletedNCT02297243
Sinopsys Lacrimal Stent Indicated for Sinus Irrigation
The Sinopsys Lacrimal Stent Indicated for Sinus Irrigation Via Transcaruncular Ethmoid Sinus Access in Patients With Moderate to Severe Chronic Rhinosinusitis With Ethmoid Sinus Involvement
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Sinopsys Surgical · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect preliminary clinical data related to the safety and performance of the Sinopsys Lacrimal Stent.
Detailed description
For purposes of this clinical study, the Sinopsys Lacrimal Stent is intended to provide a means of administering saline sinus irrigation via a transcaruncular-ethmoid sinus access in patients with moderate to severe chronic rhinosinusitis with ethmoid involvement. The purpose of the administration of saline irrigation is to reduce the intensity of symptoms of chronic rhinosinusitis in this patient population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sinopsys Lacrimal Stent | The Sinopsys Lacrimal Stent is indicated for use to create a transcaruncular ethmoid sinus access. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2014-11-21
- Last updated
- 2016-02-12
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02297243. Inclusion in this directory is not an endorsement.